GlassScriptPhysician profile
Shayef A Gabasha
NPI 1639596265
$14,325.27
in general payments reported to CMS, 2019-2025
30 companies · $1,776 in 2025
The $1,776 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.12 · 2021: $1,020 · 2022: $2,709 · 2023: $4,563 · 2024: $4,175 · 2025: $1,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,680 · Travel and Lodging: $4,833 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,680.40 |
| Travel and Lodging | $4,832.77 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,021.47 | 2022-2025 | Aveir, Mitraclip, Amplatzer Amulet |
| Medtronic, INC. | $2,452.96 | 2022-2024 | Corevalve Evolut R, Symplicity G3 |
| Edwards Lifesciences Corporation | $1,488.51 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $705.84 | 2019-2025 | Watchman Flx |
| Abiomed | $697.89 | 2023-2025 | Impella |
| Inari Medical, INC. | $517.74 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $420.93 | 2021-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $365.08 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Acist Medical Systems, INC. | $267.00 | 2021 | |
| Biosense Webster, INC. | $245.01 | 2025 | Carto 3, Nuvision Ice Catheter |
| Terumo Medical Corporation | $186.00 | 2021-2022 | |
| Chiesi USA, INC. | $151.45 | 2021-2022 | |
| Teleflex LLC | $135.45 | 2022-2023 | Vascband |
| Penumbra, INC. | $116.06 | 2021 | |
| Novartis Pharmaceuticals Corporation | $81.09 | 2023-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $74.47 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $58.12 | 2023-2024 | Fasenra |
| Bridgebio Pharma, INC. | $46.58 | 2025 | Attruby |
| Kiniksa Pharmaceuticals, LTD. | $44.48 | 2022 | |
| Angiodynamics, INC. | $39.22 | 2024 | Alphavac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.52 | 2022-2024 | Lifevest |
| Irhythm Technologies, INC. | $30.78 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Amgen INC. | $22.96 | 2022 | |
| Alexion Pharmaceuticals, INC. | $20.63 | 2022 | |
| Verona Pharma, INC. | $19.14 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $18.50 | 2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $16.72 | 2022 | |
| Philips North America LLC | $16.16 | 2023 | |
| Pfizer INC. | $14.85 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shayef Gabasha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.